[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Derwich, Katarzyna
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group]. [electronic resource] - Przeglad lekarski 2004 - 49-52 p. digital
Publication Type: Journal Article
0033-2240
Adolescent
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Asparaginase--administration & dosage
Bone Marrow--pathology
Bone Neoplasms--secondary
Central Nervous System Neoplasms--secondary
Child
Child, Preschool
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Female
Humans
Infant
Infant, Newborn
Male
Mercaptopurine--administration & dosage
Methotrexate--administration & dosage
Poland--epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prednisone--administration & dosage
Prognosis
Remission Induction
Retrospective Studies
Risk Factors
Secondary Prevention
Survival Analysis
Testicular Neoplasms--secondary
Time Factors
Treatment Outcome
Vincristine--administration & dosage
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group]. [electronic resource] - Przeglad lekarski 2004 - 49-52 p. digital
Publication Type: Journal Article
0033-2240
Adolescent
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Asparaginase--administration & dosage
Bone Marrow--pathology
Bone Neoplasms--secondary
Central Nervous System Neoplasms--secondary
Child
Child, Preschool
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Female
Humans
Infant
Infant, Newborn
Male
Mercaptopurine--administration & dosage
Methotrexate--administration & dosage
Poland--epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prednisone--administration & dosage
Prognosis
Remission Induction
Retrospective Studies
Risk Factors
Secondary Prevention
Survival Analysis
Testicular Neoplasms--secondary
Time Factors
Treatment Outcome
Vincristine--administration & dosage